Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long‐term quality of life and symptom burden
- 11 February 2010
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 105 (5), 652-658
- https://doi.org/10.1111/j.1464-410x.2009.08815.x
Abstract
To assess and identify factors associated with the long-term health-related quality of life (HRQL) of prostate cancer survivors managed expectantly, as patients with low-risk prostate cancer can be managed with active surveillance (AS), but research on associated long-term HRQL is scarce. From the population-based Eindhoven Cancer Registry, 71 men managed with AS were matched with 71 survivors who had similar demographic and clinical characteristics but treated with external beam radiotherapy (RT). All were diagnosed between 1994 and 1998. HRQL data were collected 5-10 years after diagnosis. Patients completed generic- (Short Form-36) and cancer-specific (Quality of Life - Cancer Survivors) HRQL instruments, and symptom burden (Expanded Prostate Cancer Index, Sexual Activity) questionnaires. Patients on AS were comparable to those treated with RT for most generic- and disease-specific HRQL dimensions. Patients treated with RT had poorer mean (sd) bowel function scores, of 87.1 (13.1) vs 92.8 (10.7) (P < 0.001), more bother with bowel function, at 85.0 (16.4) vs 93.7 (10.1) (P < 0.001), and more problems with getting an erection (68% vs 47%, P = 0.005). Multivariate regression analyses (corrected for comorbidity and clinical disease progression) indicated that the management strategy independently predicted differences in physical functioning, bodily pain, spiritual and total well-being, and bowel function and bowel bother. Patients managed expectantly at initial diagnosis (AS) have comparable HRQL and a lower symptom burden than patients treated with RT up to 10 years after the diagnosis.Keywords
This publication has 29 references indexed in Scilit:
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- The Relationship Between Anxiety and Time to Treatment for Patients With Prostate Cancer on SurveillanceJournal of Urology, 2007
- Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experienceBJU International, 2007
- Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptanceBJU International, 2007
- Does active surveillance for men with localized prostate cancer carry psychological morbidity?BJU International, 2007
- Doctors’ and Patients’ Preferences for Participation and Treatment in Curative Prostate Cancer RadiotherapyJournal of Clinical Oncology, 2007
- Watching, waiting and uncertainty in prostate cancerJournal of Clinical Nursing, 2007
- Do Patients With Localized Prostate Cancer Treatment Really Want More Aggressive Treatment?Journal of Clinical Oncology, 2006
- Long‐term quality of life among Dutch prostate cancer survivorsCancer, 2006
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987